September 20, 2024 — This year, the Lasker-DeBakey Clinical Medical Research Award recognizes research on GLP-1 receptor biology that is revolutionizing obesity medicine. This is a revolution that is sending shockwaves through all of healthcare and indeed through society. Revolutions are uncomfortable and many people look at progress such as this with regretful nostalgia or outright fear. So we […]
June 26, 2023 — “We may be on the cusp of an era of astonishing innovation – the limits of which aren’t even clear yet,” writes David Wallace-Wells in the New York Times. Among other breakthroughs, he cites the transformation in care that semaglutide and tirzepatide are bringing for the most prevalent chronic disease in the world – obesity. […]
March 20, 2022 — “Focusing on cancer, focusing on obesity, focusing on diabetes, a whole range of diseases … we’re going to make significant breakthroughs.” This in a nutshell is the aspiration for ARPA-H, as voiced by President Joe Biden. It is a new agency with a billion dollars of funding for the next three years, passed in a bipartisan […]
